Ad is loading...
KNTPF
Price
$0.16
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
MLEC
Price
$0.83
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
24 days until earnings call
Ad is loading...

KNTPF vs MLEC

Header iconKNTPF vs MLEC Comparison
Open Charts KNTPF vs MLECBanner chart's image
KINTOR PHARMACEUTICAL
Price$0.16
Change-$0.00 (-0.00%)
Volume$20K
CapitalizationN/A
Moolec Science SA
Price$0.83
Change-$0.00 (-0.00%)
Volume$16.12K
CapitalizationN/A
KNTPF vs MLEC Comparison Chart
Loading...
MLEC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
KNTPF vs. MLEC commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNTPF is a Buy and MLEC is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (KNTPF: $0.16 vs. MLEC: $0.83)
Brand notoriety: KNTPF and MLEC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KNTPF: 165% vs. MLEC: 67%
Market capitalization -- KNTPF: $61.48M vs. MLEC: $31.84M
KNTPF [@Biotechnology] is valued at $61.48M. MLEC’s [@Biotechnology] market capitalization is $31.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KNTPF’s FA Score shows that 0 FA rating(s) are green whileMLEC’s FA Score has 0 green FA rating(s).

  • KNTPF’s FA Score: 0 green, 5 red.
  • MLEC’s FA Score: 0 green, 5 red.
According to our system of comparison, KNTPF is a better buy in the long-term than MLEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLEC’s TA Score shows that 1 TA indicator(s) are bullish.

  • MLEC’s TA Score: 1 bullish, 5 bearish.

Price Growth

KNTPF (@Biotechnology) experienced а 0.00% price change this week, while MLEC (@Biotechnology) price change was -5.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

MLEC is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNTPF($61.5M) has a higher market cap than MLEC($31.8M). KNTPF YTD gains are higher at: -7.031 vs. MLEC (-66.220).
KNTPFMLECKNTPF / MLEC
Capitalization61.5M31.8M193%
EBITDAN/AN/A-
Gain YTD-7.031-66.22011%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
MLEC
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
29%
Momentum
ODDS (%)
Bearish Trend 3 days ago
50%
MACD
ODDS (%)
Bearish Trend 3 days ago
41%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 26 days ago
49%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
MLEC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIVPX10.53-0.04
-0.38%
Fidelity Advisor International Value M
MXTFX7.48-0.07
-0.93%
Empower Small Cap Value Instl
MAEIX71.41-0.94
-1.30%
MoA Equity Index Fund
MFSIX11.34-0.19
-1.65%
Madison Sustainable Equity I
TMIFX10.34-0.18
-1.71%
Transamerica Mid Cap Growth R4

KNTPF and

Correlation & Price change

A.I.dvisor tells us that KNTPF and SYRS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNTPF and SYRS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNTPF
1D Price
Change %
KNTPF100%
N/A
SYRS - KNTPF
31%
Poorly correlated
-5.74%
MLEC - KNTPF
27%
Poorly correlated
+0.12%
KNSA - KNTPF
20%
Poorly correlated
-2.38%
UNCY - KNTPF
20%
Poorly correlated
+2.68%
RLFTY - KNTPF
20%
Poorly correlated
-9.74%
More

MLEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLEC has been loosely correlated with SPRB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MLEC jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLEC
1D Price
Change %
MLEC100%
+0.12%
SPRB - MLEC
51%
Loosely correlated
-5.83%
WINT - MLEC
49%
Loosely correlated
-3.98%
CTMX - MLEC
42%
Loosely correlated
-9.00%
AAVXF - MLEC
38%
Loosely correlated
N/A
BLPH - MLEC
34%
Loosely correlated
N/A
More